IntroductionEscherichia coli strains are important pathogens in animals and humans, and are normal commensals in intestinal tracts. The β-lactam group of antibiotics has been intensely used in human and veterinary medicine as infectious disease treatments (1). Extended-spectrum betalactamases (ESBLs) hydrolyze oxyimino-cephalosporins and give resistance to bacteria against the penicillins, cephalosporins (first, second, and third generations), and aztreonam. They are repressed by β-lactamase inhibitors. ESBLs are classified as β-lactamases containing three main families: TEM (named after the patient Temoneria), SHV (sulfhydryl reagent variable), and CTX-M (active on cefotaxime, first isolated in Munich) (2). The prevalence of CTX-M-type β-lactamase-producing E. coli has increased in poultry over the last decade (3).Increasing prevalence of ESBL-producing E. coli in poultry has become a major zoonotic risk because of possible transmission from broilers to humans (3). In addition, ESBL-producing E. coli strains that may have multidrug resistance (MDR) and cause therapeutic problems have been reported in human and veterinary practice (4). The alarming spread of ESBL-producing Enterobacteriaceae poses a serious public health threat and has attracted the attention of scientists, politicians, and the general public globally. There was no previous study about the presence, prevalence, and molecular epidemiology of ESBL-producing E. coli isolates from broilers in Turkey. The aim of the present study was to investigate the resistance phenotype and genotyping characteristics of ESBL-carrying E. coli strains in healthy broilers in Turkey.
Materials and methods
Samples, isolations, and identificationFrom January to April 2012, 300 samples were collected from cloacal samples of healthy slaughterhouse broilers in two regions of Turkey. Broiler cloacal samples were obtained from a total of 30 different poultry houses